Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety

Christoph KellinghausDepartment of Neurology, Klinikum Osnabrück, GermanyAbstract: Lacosamide (LCM) is a novel agent that has been developed as an antiepileptic drug. In vitro studies suggest that LCM modulates voltage-gated sodium channels by enhancing their slow inactivation. In addition,...

Full description

Saved in:
Bibliographic Details
Main Author: Christoph Kellinghaus (Author)
Format: Book
Published: Dove Medical Press, 2009-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available